-
The Human Advantage
Ear, Nose, & Throat Testing
Ordering Options
PCR Testing
- Ear, Nose,& Throat Panel
Turnaround Time
≤ 24 hours *Cost
All tests are billed to medical insurance.For those without medical insurance, please call for details.
Resources
* Turnaround time starts when sample is received at the laboratory.
Ear, Nose, & Throat Testing
Viruses are a leading cause of ear, nose, and throat (ENT) ailments. Our ENT Test Panel is specifically designed to detect viral infections responsible for common conditions such as the common cold, influenza, and viral pharyngitis.
Utilizing advanced molecular testing and serological assays, this panel can accurately identify the specific viral strains causing the infection. By pinpointing the exact virus involved, healthcare professionals can offer targeted treatment recommendations, effectively manage symptoms, and help prevent the spread of contagious infections, medical providers have fast and accurate diagnostic and treatment options in less than 24 hours.
Ear, Nose, & Throat Panel
| Bacterial Targets |
|---|
| Acinetobacter baumannii |
| Aeromonas species |
| Alloiococcus otitis |
| Bacteroides fragilis |
| Citrobacter species |
| Corynebacterium amycolatum |
| Corynebacterium urealyticum |
| Cutibacterium acnes |
| Enterobacter cloacae |
| Enterococcus faecalis |
| Enterococcus faecium |
| Haemophilus influenzae |
| Klebsiella aerogenes |
| Klebsiella oxytoca |
| Klebsiella pneumoniae |
| Moraxella catarrhalis |
| Moraxella lacunata |
| Peptostreptococcus species |
| Prevotella bivia |
| Pseudomonas aeruginosa |
| Serratia marcescens |
| Staphylococcus aureus |
| Staphylococcus epidermidis |
| Staphylococcus haemolyticus |
| Staphylococcus lugdunensis |
| Staphylococcus saprophyticus |
| Stenotrophomonas maltophilia |
| Streptococcus pneumoniae |
| Streptococcus pyogenes |
| Vibrio species |
| Fungal Targets |
|---|
| Aspergillus species |
| Candida albicans |
| Candida auris |
| Candida glabrata |
| Candida parapsilosis |
| Candida tropicalis |
| Escherichia coli |
| Streptococcus agalactiae |
| Resistance Genes |
|---|
| Beta Lactamase (CTX-M-Grp1) |
| Beta Lactamase (IMP) |
| Beta Lactamase (VIM) |
| Carbapenem (KPC) |
| Carbapenem (NDM) |
| Carbapenem (OXA-48) |
| Vancomycin (VanA) |
| Vancomycin (VanB) |
| Antimicrobial Agents | PO | IV | IM | PV | SUP | TOP |
|---|---|---|---|---|---|---|
| Amoxicillin | ✔ | |||||
| Amoxicillin-Clavulanate | ✔ | |||||
| Amphotericin B | ✔ | ✔ | ||||
| Ampicillin | ✔ | ✔ | ||||
| Azithromycin | ✔ | |||||
| Aztreonam | ✔ | ✔ | ||||
| Bacitracin | ✔ | ✔ | ||||
| Bactrim | ✔ | |||||
| Bactrim DS | ✔ | |||||
| Cefazolin | ✔ | ✔ | ||||
| Cefdinir | ✔ | |||||
| Cefixime | ✔ | |||||
| Ceftazidime | ✔ | |||||
| Ceftriaxone | ✔ | ✔ | ||||
| Ceftriaxone | ✔ | |||||
| Cefuroxime | ✔ | |||||
| Cephalexin | ✔ | |||||
| Ciprofloxacin | ✔ | |||||
| Clindamycin | ✔ | |||||
| Clindamycin cream 2% | ✔ | |||||
| Daptomycin | ✔ | ✔ | ||||
| Doxycycline | ✔ | |||||
| Erythromycin | ✔ | |||||
| Fluconazole | ✔ | |||||
| Flucytosine | ✔ | |||||
| Fosfomycin | ✔ | |||||
| Itracinazole | ✔ | |||||
| Levofloxacin | ✔ | |||||
| Linezolid | ✔ | |||||
| Metronidazole | ✔ | |||||
| Metronidazole gel 0.75% | ✔ | |||||
| Micafungin | ✔ | |||||
| Minocycline | ✔ | |||||
| Mupirocin 2% | ✔ | |||||
| Nitrofurantoin | ✔ | |||||
| Nitrofurantoin (macrobid) | ✔ | |||||
| Piperacillin - Tazobactam | ✔ | ✔ | ||||
| Terbinafine | ✔ | |||||
| TMP-SMX DS | ✔ | |||||
| Tripple Antibiotic Bac/Neo/Pol | ✔ | |||||
| Vancomycin | ✔ | ✔ |
Test Limitations
This nucleic acid amplification test was developed, and its performance characteristics determined with polymerase chain reaction (PCR) by Advanta Genetics. This is a laboratory developed test and has not been cleared by the FDA. Advanta Genetics is regulated by CLIA as qualified to perform high complexity testing and is accredited by the College of America Pathologist (CAP). This test is for clinical purpose and should not be regarded as investigational or for research purposes.